Insurance Guide · Updated March 2026

How to Get Insurance to Cover GLP-1 Medications in 2026

Brand-name Wegovy costs $1,349/month at list price. Zepbound costs $1,086/month. But many people pay $0-$50/month with insurance. The difference comes down to knowing how the system works: which insurers cover what, how to get prior authorization approved, what to do when you get denied, and which manufacturer savings programs actually reduce your copay.

Which Insurers Cover GLP-1s for Weight Loss?

Coverage varies dramatically by insurer, plan type, and employer. Here is the general picture as of early 2026:

Key distinction: Ozempic and Mounjaro are approved for type 2 diabetes. Wegovy and Zepbound are approved for weight management. Insurance coverage is generally better for the diabetes indications. If you have type 2 diabetes, your path to coverage is much simpler. For a clinical comparison of these medications, see our Mounjaro vs Ozempic breakdown.

Important trend: Some employers and insurers are pulling back on GLP-1 weight loss coverage due to high costs. Blue Cross Blue Shield of Massachusetts and several large employers have restricted or eliminated GLP-1 coverage for weight loss in 2025-2026. Check your specific plan’s formulary before assuming you are covered.

Step-by-Step: Getting Prior Authorization Approved

Most insurers require prior authorization (PA) before covering GLP-1 medications for weight loss. Here is how the process typically works:

Step 1: Confirm Your Plan Covers GLP-1s

Call the number on the back of your insurance card. Ask specifically: “Does my plan cover Wegovy (or Zepbound) for weight management?” Get the answer in writing if possible. If they say no, skip to the manufacturer savings section below.

Step 2: Meet the Clinical Criteria

Most insurers require:

• BMI of 30 or higher, OR BMI of 27+ with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea)
• Documentation of prior weight loss attempts (usually 3-6 months of documented diet and exercise, or previous use of a weight loss program)
• No contraindications (personal or family history of medullary thyroid carcinoma, MEN 2 syndrome, pancreatitis)

Tips:

• If your doctor has not documented your BMI and weight-related conditions in your medical record, ask them to do so at your next visit. Prior auth reviewers look at your chart.
• Some insurers require “step therapy,” meaning you must try a cheaper medication first (usually metformin or Contrave) before they will approve a GLP-1. Ask your insurer if this applies.

Step 3: Your Doctor Submits the Prior Auth

Your prescribing physician (or a telehealth platform like Ro or Calibrate that handles insurance) submits the PA request. This includes:

• Your diagnosis (obesity, overweight with comorbidities)
• Clinical rationale for GLP-1 medication
• Documentation of prior weight loss attempts
• Relevant lab work (BMI, A1C, lipid panel)

Step 4: Wait (and Follow Up)

Prior authorization typically takes 5 to 14 business days. Some insurers have urgent/expedited review options. Follow up at the 7-day mark if you have not heard back.

Step 5: If Approved

Your pharmacy fills the prescription. Your copay depends on your plan. Manufacturer savings cards (see below) can reduce copays further.

Step 6: If Denied

Do not give up. See the appeal section below.

What to Do When You Get Denied

Denial rates for GLP-1 prior authorization are high, especially for weight loss (vs. diabetes) indications. Here is how to appeal:

Level 1: Internal Appeal

• Request a copy of the denial letter. It must state the specific reason for denial.
• Your doctor writes a letter of medical necessity explaining why this specific medication is needed for your health.
• Include supporting documentation: lab results, BMI history, comorbidity documentation, failed prior treatments.
• Many denials are overturned at this stage simply by providing better documentation.

Level 2: Peer-to-Peer Review

• Your doctor can request a peer-to-peer review, where they speak directly with the insurer’s medical director.
• This is often more effective than written appeals because your doctor can make the clinical case in real-time.

Level 3: External Review

• If internal appeals fail, you can request an independent external review through your state’s insurance department.
• The external reviewer is not employed by your insurer and makes an independent determination.

Level 4: State Insurance Commissioner

• File a complaint with your state’s insurance commissioner if you believe the denial was improper.
• This is a last resort but can be effective, especially if the denial contradicts the insurer’s own published formulary criteria.

Success rates: While specific GLP-1 appeal success rates are not widely published, general prior authorization appeal overturn rates range from 40-75% depending on the insurer and documentation quality. Appealing is worth the effort.

Manufacturer Savings Programs

Even with insurance, your copay can be high. Manufacturer savings cards can reduce it:

Wegovy (Novo Nordisk)

• Wegovy Savings Card: Eligible commercially insured patients may pay as little as $0-$25/month
• NovoCare self-pay: $199/month for starter doses (0.25mg, 0.5mg), $349/month for higher doses (as of early 2026)
• Oral Wegovy (pill): $149/month (promotional pricing through Ro and other partners)

Zepbound (Eli Lilly)

• Zepbound Savings Card: Eligible commercially insured patients may pay as little as $25/month
• LillyDirect self-pay: $349/month for 2.5mg, $499/month for 5mg+
• Savings card not valid for government insurance (Medicare, Medicaid, Tricare)

Ozempic (Novo Nordisk)

• Ozempic Savings Card: Eligible patients may pay as little as $25/month
• Note: Ozempic is approved for type 2 diabetes. Using it for weight loss is off-label and may affect insurance coverage.

Mounjaro (Eli Lilly)

• Mounjaro Savings Card: Eligible commercially insured patients pay $25/month or less
• Approved for type 2 diabetes. Weight loss use is off-label.

Eligibility: Manufacturer savings cards typically require commercial (private) insurance. They do not work with Medicare, Medicaid, Tricare, or other government-funded insurance. If you have government insurance, the manufacturer savings cards are not available to you.

HSA and FSA for GLP-1 Medications

GLP-1 medications prescribed for a diagnosed medical condition (obesity, type 2 diabetes) are generally eligible for HSA and FSA reimbursement.

What qualifies:

• The prescription itself (medication cost)
• Doctor visit copays related to GLP-1 treatment
• Lab work ordered as part of treatment
• Telehealth platform membership fees (if treating a medical condition)

What you need:

• A Letter of Medical Necessity (LOMN) from your prescribing physician
• Receipts for all expenses
• Check with your specific HSA/FSA administrator for their requirements

Telehealth platforms that accept HSA/FSA directly: Ro, Hims, MEDVi, SkyRx, Eden, Found.

Medicare and GLP-1s in 2026

As of early 2026, Medicare Part D does not cover GLP-1 medications prescribed for weight loss (Wegovy, Zepbound). It does cover GLP-1s prescribed for type 2 diabetes (Ozempic, Mounjaro).

The TREAT Act (Treat and Reduce Obesity Act) has been introduced in Congress multiple times to expand Medicare coverage to include FDA-approved anti-obesity medications. As of March 2026, this has not been signed into law. Progress on this issue has been slow despite bipartisan support.

If you are on Medicare and want a GLP-1 for weight loss, your options are:

• Self-pay through manufacturer programs (LillyDirect, NovoCare)
• Compounded versions through telehealth platforms (while available)
• Check if your Medicare Advantage plan has any supplemental weight management benefits
• Use our body composition tool to track your progress regardless of which payment path you choose

Platforms That Handle Insurance for You

Not all telehealth platforms handle insurance. Here is who does:

If insurance coverage matters to you, Calibrate and Ro are the strongest options for handling the prior authorization process.

The Bottom Line

Getting insurance to cover GLP-1 medications takes work. But the difference between $0-$50/month and $300-$1,000+/month is thousands of dollars a year. Coverage also varies by state. Check availability for providers in California or Texas if those are your states. Check your plan first, document your medical history, have your doctor submit a strong prior authorization, and appeal if denied. Manufacturer savings cards can reduce copays even further.

If your insurance does not cover GLP-1s and you cannot afford brand-name self-pay, compounded versions through telehealth platforms remain an option (with regulatory caveats). See our compounded vs brand-name guide and cheapest GLP-1 guide for all your cost-reduction options. Our GLP-1 without insurance guide also covers every cash-pay path in detail.

FAQ

Does insurance cover Wegovy for weight loss?

Some commercial insurance plans cover Wegovy for weight management with prior authorization. Coverage varies by insurer, plan type, and employer. Call the number on your insurance card to ask specifically. Medicare Part D does not cover Wegovy for weight loss as of 2026.

How long does prior authorization take for GLP-1 medications?

Typically 5 to 14 business days. Some insurers offer expedited review. Follow up at the 7-day mark if you have not received a decision. Telehealth platforms like Ro and Calibrate handle the prior auth process on your behalf.

What if my insurance denies GLP-1 coverage?

Appeal. Request a copy of the denial letter, have your doctor write a letter of medical necessity, and submit an internal appeal with supporting documentation (BMI history, comorbidities, failed prior treatments). Request a peer-to-peer review if the written appeal is denied. General appeal overturn rates are 40-75%.

Can I use an HSA or FSA for GLP-1 medications?

Yes, when prescribed for a diagnosed medical condition (obesity, type 2 diabetes). You will need a Letter of Medical Necessity from your prescribing physician. Both the medication cost and related medical expenses (doctor visits, lab work, telehealth membership fees) may qualify. Check with your specific HSA/FSA administrator.

Does Medicare cover Mounjaro or Ozempic?

Medicare Part D covers Mounjaro and Ozempic when prescribed for type 2 diabetes. It does not cover Wegovy or Zepbound when prescribed for weight loss. The TREAT Act to expand Medicare coverage to anti-obesity medications has been introduced in Congress but has not been signed into law as of March 2026.

Related

Guides:

• Cheapest GLP-1 Online · Insurance Coverage · Side Effects
• Mounjaro Dosage Guide · Oral vs Injectable · Exercise and Muscle
• Compounded vs Brand-Name · Without Insurance

Provider Reviews: Ro · Hims · MEDVi · Found · Calibrate

Compare: All Providers · Best GLP-1 Programs · All Guides